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Introduction
Nicotinic acetylcholine receptors (nAChRs) are
members of the Cys-loop superfamily of pentameric
ligand-gated ion channels, which include GABA (A
and C), serotonin, and glycine receptors. Currently, 12
neuronal nAChR subunits have been identified (F2–10
and G2–4) and are generally grouped into F subunits,
which contain two adjacent cysteine residues essen-
tial for ACh binding, and G subunits, which lack these
residues. The majority of neuronal nAChRs fall into
two categories: those that bind agonist with high affin-
ity (nMconcentrations); and those that bind with lower
affinity (RM concentrations). The low-affinity recep-
tors are presumably homomeric F7 receptors that are
F-bungarotoxin sensitive, whereas F4G2 nAChRs
account for >90% of the high-affinity nicotinic recep-
tors in the brain (Whiting and Lindstrom, 1986). Their
physiological contributions to neurotransmission, sig-
naling, and behavior are not completely understood.
Precise mapping of subcellular and neuroanatomical
localizations of neuronal nAChR subunits will help
elucidate the physiological role of neuronal nAChRs
and their role in nicotine addiction.
Cholinergic neurons are limited to a number of
discrete CNS localizations (Woolf, 1991), which make
sparse projections to a wide distribution of high-
affinity nicotinic receptors in the brain. The behav-
ioral basis for nicotine addiction is complex and
varied among tobacco users but includes pleasure,
improvement in cognitive function, attention, learn-
ing and memory, reduction in stress and anxiety,
decreased appetite, relieved depression, and suc-
cumbing to social pressures (Picciotto, 2003). Detailed
mapping of the anatomical distribution of the primary
target of nicotine, the nAChR, would provide clues as
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to how nicotine impacts on specific behaviors. Much
work on addiction has focused on the mesolimbic
circuit in the brain, and both F4 and G2 subunits have
been implicated in mediating nicotine addiction
(Picciotto et al., 1998; Tapper et al., 2004).
A variety of techniques, including antibody label-
ing, in situ hybridization with cRNA probes, and
radioactively labeled ligands, have been used to ascer-
tain nAChR distribution in the brain. This paper will
review what is known about localization of neuronal
nAChRs in the CNS, with an emphasis on F4G2 recep-
tors and their location in the circuits of addiction.
Subcellular Neuronal nAChR Localization
Although most nicotinic receptor signaling
appears to be presynaptic in the CNS (McGehee et
al., 1995; Gray et al., 1996), there is some evidence
for postsynaptic nicotinic signaling (Roerig et al.,
1997; Alkondon et al., 1998). The effect of neuronal
nAChR activation depends on the subcellular local-
ization of the receptor. Nicotinic receptors expressed
on dendrites and soma might mediate fast synaptic
transmission and contribute to neuronal excitability
through generation of excitatory postsynaptic
potentials. (Recent evidence shows cholinergic
terminals located remotely from F-bungarotoxin
labeling of F7 nAChRs in both ventral tegmental area
(VTA) and nucleus accumbens. This suggests that
neuronal nAChRs may be activated by paracrine or
volume transmission of ACh [Jones and Wonnacott,
2004]). In addition, nAChRs are expressed at axon
terminals (Jones et al., 2001), where activation
modulates neurotransmitter release through cal-
cium influx and/or terminal depolarization. Nicotinic
receptors modulate the release of norepinephrine,
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glutamate, GABA, and dopamine. Currently, the
predominant role of nAChRs is thought to be in
modulating neurotransmission presynaptically.
CNS Localization of F4G2 Nicotinic Receptors
Radioligand binding, using L-[3H]nicotine, in mice
shows moderate binding in many areas of the brain,
including the parietal cortex, cingulate cortex, subicu-
lum, substantia nigra, superior colliculus, medial
geniculate nucleus, optic nerve dorsal raphe, latero-
dorsal tegmental nucleus, and retrospenial cortex. Low
levels of nicotine binding include the medial septum,
nucleus accumbens, caudate putamen, hippocampus,
and olfactory tubercle (Marks et al., 1992). The high-
est density of nicotine binding is in the interpedun-
cular nucleus, followed by the medial habenula, many
thalamic nuclei, ventral lateral and dorsal lateral genic-
ulate nuclei, and optic tract nucleus. Virtually no bind-
ing was found in the cerebellum.
There appears to be very similar, though not
exact, correspondence between the distribution of 
L-[3H]nicotine binding and F4 mRNA expression in
the CNS (Wada et al., 1989; Marks et al., 1992). The
discrepancy might be due to targeting of F4 subunit
proteins to axons and presynaptic terminals while
the mRNA resides in the soma. Immunolabeling of
G2 nAChR subunits with MAb270 also shows an
expression pattern very similar to L-[3H]nicotine
binding (Clarke et al., 1985; Swanson et al., 1987).
Immunolabeling with MAb270 shows discrete
expression at all levels of the brain and spinal cord,
with particularly strong labeling in the interpedun-
cular nucleus, the medial habenula, the thalamus,
and the superior colliculus.
F4 and G2 nAChR subunit mRNAs are detected
in the nervous system as early as E11 in rats. Both
subunit mRNAs are expressed in the CNS and the
PNS. However, F4 expression is down-regulated in
the PNS to undetectable levels by E15, whereas G2
mRNA expression is maintained in the PNS until
adulthood (Zoli et al., 1995).
Localization of F4G2 nAChRs in the Mesolimbic
System
Although nAChRs are expressed in many CNS
regions, nicotine’s major addictive effects are thought
to be mediated through the dopaminergic mesocorti-
colimbic pathways. Dopaminergic neurons, originat-
ing in the VTA, project to nucleus accumbens and
prefrontal cortex. Three cell types in the VTA, dopamin-
ergic neurons, GABAergic neurons, and glutamater-
gic axonal terminals from the prefrontal cortex, all
contain nicotinic receptors(Mansvelder and McGehee,
2000; Mansvelder et al., 2002). The balance of excita-
tory and inhibitory inputs onto VTA dopaminergic
neurons affects dopamine release in the nucleus
accumbens and is likely critical for the reinforcing
effects of nicotine. F4 and G2 mRNAs are expressed
in nearly every dopaminergic and GABAergic neuron
in the VTA, whereas F2 is not expressed at all (Klink
et al., 2001). F7 nAChR subunit mRNA is found in
40% of either cell type; G4 is sparsely distributed in
both GABAergic (25%) and dopaminergic neurons
(12%). Meanwhile, GABAergic neurons express
mRNA from a similar variety of neuronal nAChRs as
dopaminergic neurons. However, F5, F6, and G3
mRNAs express at lower percentages of GABAergic
(<25%) than dopaminergic (>70%) neurons.
The VTA and substantia nigra pars compacta
(SNpc) contain moderate to high levels of F4G2
nAChR mRNA (Wada et al., 1989). Antibody label-
ing of F4 and G2 subunits in the soma and dendrites
of the SNpc shows colocalization in >90% of tyrosine
hydroxylase–positive dopaminergic neurons (Arroyo-
Jimenez et al., 1999; Jones et al., 2001). Immunoelectron
microscopic studies show that F4 subunits are located
in the perikarya and dendritic shafts but not spines,
and very scarcely but authentically in postsynaptic
membranes in dopaminergic neurons (Arroyo-
Jimenez et al., 1999). G2 subunits show a similar local-
ization pattern in dopaminergic neurons in the SNpc
but also show immunoelectron microscopic evidence
of presynaptic localization in dopaminergic axonal
terminals in the dorsal striatum (Jones et al., 2001).
Immunoprecipitation and 6-hydroxydopamine
lesioning experiments suggest that F4 subunits are
also located in dopaminergic projections in the dorsal
striatum (Zoli et al., 2002). However, given the appar-
ent similarity of ion channel composition and projec-
tions of dopaminergic neurons in the VTA and SNpc,
it is presently unknown why nicotine preferentially
stimulates dopamine release from the mesoaccum-
bens but not the nigrostriatal system (Imperato et al.,
1986; Benwell and Balfour, 1997). An advancement of
techniques, using a combination of modern mouse
genetic engineering, genetically encoded fluorescent
proteins as tags, and a modern laser scanning confo-
cal or two-photon microscope, can shed new light on
this unresolved issue.
Conclusions
In addition to knowledge on nAChR localization
gained using conventional techniques of ligand bind-
ing, antibody labeling, and in situ hybridization, the
field would greatly benefit from the exploitation of
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modern imaging technology, the use of genetically
encoded fluorescent proteins, and mutant mice
genetic engineering. Knock-in mice with green
fluorescent proteins tagged to the GAT1 protein, for
example, has enabled high resolution and accurate
quantitative imaging in subcellular neuroanatomi-
cal regions (Chiu et al., 2002). Improved fluorescence-
based imaging microscopy enables deeper tissue
penetration, less damage to live tissue with photon
excitation, more accurate spectral separation, and
high-resolution 3D reconstruction of cells. Such
technology would permit imaging of nicotinic
receptors in live neurons, deep into brain tissue, and
perhaps reveal the spatial arrangement of neuronal
circuitry. If using the appropriate pairs of spectral
variants of fluorescent proteins tagged to nicotinic
receptor subunits, one can also assess receptor
assembly at subcellular resolution (Nashmi et al.,
2003). These emerging technologies have allowed
researchers to examine biology with exquisite detail
as never before.
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